Twenty-First Century Diseases: Commonly Rare and Rarely Common?

@article{Daunert2017TwentyFirstCD,
  title={Twenty-First Century Diseases: Commonly Rare and Rarely Common?},
  author={S. Daunert and G. Sittampalam and P. Goldschmidt-Clermont},
  journal={Antioxidants & redox signaling},
  year={2017},
  volume={27 9},
  pages={
          511-516
        }
}
  • S. Daunert, G. Sittampalam, P. Goldschmidt-Clermont
  • Published 2017
  • Biology, Medicine
  • Antioxidants & redox signaling
  • Alzheimer's drugs are failing at a rate of 99.6%, and success rate for drugs designed to help patients with this form of dementia is 47 times less than for drugs designed to help patients with cancers ( www.scientificamerican.com/article/why-alzheimer-s-drugs-keep-failing/2014 ). How can it be so difficult to produce a valuable drug for Alzheimer's disease? Each human has a unique genetic and epigenetic makeup, thus endowing individuals with a highly unique complement of genes, polymorphisms… CONTINUE READING
    1 Citations

    Topics from this paper

    References

    SHOWING 1-10 OF 39 REFERENCES
    Genetics of cardiovascular diseases: lessons learned from a decade of genomics research in Iceland
    • 12
    Atherosclerosis, Inflammation, Genetics, and Stem Cells: 2012 Update
    • 33
    Genetics of Coronary Artery Disease.
    • 245
    • PDF
    Narrative Review: Harnessing Molecular Genetics for the Diagnosis and Management of Hypertrophic Cardiomyopathy
    • 83
    • PDF
    Atherosclerosis: Successes, Surprises, and Future Challenges.
    • 115
    Precision medicine in cardiology
    • 107
    Unraveling the Truth About Antioxidants: ROS and disease: finding the right balance
    • 82
    Molecular and Cellular Mechanisms of KSHV Oncogenesis of Kaposi's Sarcoma Associated with HIV/AIDS
    • 65
    • PDF
    Sudden Cardiac Death Caused by Coronary Heart Disease
    • 288
    KSHV and the pathogenesis of Kaposi sarcoma: listening to human biology and medicine.
    • D. Ganem
    • Medicine, Biology
    • The Journal of clinical investigation
    • 2010
    • 309
    • Highly Influential
    • PDF